Biomarkers, especially biochemical markers, are important in osteoarthritis (OA) research,
clinical trials, and drug development and have potential for more extensive use in …

OBJECTIVE: Osteoarthritis (OA) is a chronic and slowly progressive disease for which
biomarkers may be able to provide a more rapid indication of therapeutic responses to …

Osteoarthritis (OA) is an increasingly important public health concern as the prevalence of
this disease becomes higher and higher due to the ageing population. However, in addition …

Osteoarthritis (OA), the most common and disabling form of arthritic disease, is characterized
by a slow and progressive degeneration of articular cartilage. Its etiology is multifactorial and …

The field of biomarkers is a growing one, particularly in osteoarthritis (OA). OA is the most
common disabling condition in older persons and a major cause of morbidity. While the …

In this review, we have focused on the molecular biomarkers of four distinct osteoarthritis
subtypes including inflammatory, subchondral bone remodelling, metabolic syndrome and …

The history of osteoarthritis (OA) is important because it can help broaden our perspective
on past and present controversies. The naming of OA, beginning with Heberden's nodes, is …

Objective Osteoarthritis (OA) is one of the leading causes of disability within the adult
population. Currently, its diagnosis is mainly based on clinical examination and standard …

Osteoarthritis (OA) is the most common form of arthritis affecting more than 500 million
people globally (1). It accounts for more pain and functional disability than any other …

Development of OA (OA) is multifactorial and is strongly associated with risk factors such as
aging, trauma, metabolic disorders, and obesity. Metabolic Syndrome (MetS)-associated OA …